NEW YORK, July 11, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Eco Science Solutions, Inc. (OTCMKTS:ESSI) who purchased shares between May 1, 2017 and May 19, 2017. The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (i) the Company’s plan for strategic acquisitions lacked veracity; and (ii) as a result, Defendants’ statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. On May 19, 2017, the U.S. Securities and Exchange Commission issued an order of suspension of trading, halting trading of the Company’s securities.
Shareholders have until July 24, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/eco-science-solutions-inc-2?wire=1.
Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com


McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 



